|
Volumn 6, Issue 1, 2002, Pages 37-41
|
Randomized, double-blind, placebo-controlled trial of oromucosal low-dose interferon following prednisone withdrawal for chronic hepatitis B infection in Filipino patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B ANTIBODY;
HEPATITIS B ANTIGEN;
LYMPHOBLAST INTERFERON;
PREDNISONE;
VIRUS DNA;
ADULT;
ARTICLE;
BONE MARROW SUPPRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HEPATITIS B;
HUMAN;
MALE;
PHILIPPINES;
RANDOMIZED CONTROLLED TRIAL;
SEROCONVERSION;
VIRUS REPLICATION;
|
EID: 0036299046
PISSN: 12019712
EISSN: None
Source Type: Journal
DOI: 10.1016/S1201-9712(02)90134-7 Document Type: Article |
Times cited : (5)
|
References (11)
|